13,879 papers found
Refreshing results…
Enhanced superconductivity in CuH2 monolayers
Prediction of Listed Company Innovation Ability Based on Attention Mechanism
Glucose metabolism controls human γδ T-cell-mediated tumor immunosurveillance in diabetes
Safety and efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients with preexisting antinuclear antibodies: a retrospective cohort study
Modulating the d-band centers by coordination environment regulation of single-atom Ni on porous carbon fibers for overall water splitting
Insights Into the Properties, Biological Functions, and Regulation of USP21
The balance between protective and pathogenic immune responses to pneumonia in the neonatal lung is enforced by gut microbiota
Recent knowledge of NFATc4 in oncogenesis and cancer prognosis
Selective hydrogenation of unsaturated aldehydes over Pd catalyst supported on N-doped porous carbon
Chromosome‐level genome of Pedinomonas minor (Chlorophyta) unveils adaptations to abiotic stress in a rapidly fluctuating environment
The Levelized Cost of Storage of Electrochemical Energy Storage Technologies in China
Engineering the optimum pH of β-galactosidase from Aspergillus oryzae for efficient hydrolysis of lactose
35B5 antibody potently neutralizes SARS-CoV-2 Omicron by disrupting the N-glycan switch via a conserved spike epitope
Time-activity and daily mobility patterns during pregnancy and early postpartum – evidence from the MADRES cohort
Comparative study between the effects of aged and fresh Chinese baijiu on gut microbiota and host metabolism
Platinum-free chemotherapy in the new era of immunotherapy: A phase II study of camrelizumab combined with apatinib and albumin paclitaxel in advanced non-squamous NSCLC (CAPAP-lung).
Ti3C2 MXene Nanosheets Functionalized with NaErF4:0.5%Tm@NaLuF4 Nanoparticles for Dual-Modal Near-Infrared IIb/Magnetic Resonance Imaging-Guided Tumor Hyperthermia
PointSite: A Point Cloud Segmentation Tool for Identification of Protein Ligand Binding Atoms
Upregulation of CXCL1 and LY9 contributes to BRCAness in ovarian cancer and mediates response to PARPi and immune checkpoint blockade
ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis
Missing publications? Read more about our data sources.